search.noResults

search.searching

saml.title
dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
THE MAGIC GLOVE


The hands and fingers were the second most common sites of non-battle injuries reported by service members.


into reality. For perspective, the MTEC prototype-acceleration award mechanism is instrumental in helping teams advance their prototypes toward their next major technical milestone, with the hopes that additional funding from another source will


Tose attempts have blossomed over the past several years. Since it became fully operational in January 2016, USAMRDC has awarded 176 different prototyping projects through MTEC with more than $640 million in government funding— along with an additional $87 million in cost share funds (which comes via either cash or another type of in-kind contribu- tion by the performer). Currently, MTEC has more than 117 active awards; mean- ing the opportunity that Wijesundara saw all those years ago has made a similar impression across the larger academic and business worlds as well.


CONCLUSION As it stands now, the ReHeal Glove is involved in an early feasibility study clin- ical trial with the U.S. Food and Drug Administration—a


trial funded by follow from there. According to


MTEC, the award mechanism provides that “awardees may receive up to $250,000 to achieve a technical milestone(s) that helps them secure follow-on funding.” Each prototype-acceleration awardee also receives tailored support from MTEC’s staff and associated M-Corps—a network of subject matter experts and service providers—to address business, technical and regulatory challenges associated with medical product development. This


support aims to advance the


commercialization readiness of the MTEC technology portfolio for positioning and possible funding by MTEC’s investor network.


“I was in an early meeting years ago discussing MTEC,” said Wijesundara. “And I saw very quickly the opportu- nity that was available, what they had created—the attempt to get semi-mature technology into the hands of clinicians.”


44 Army AL&T Magazine Summer 2022


CDMRP. Te device will be tested on a range of individuals—so far, two healthy volunteers have been studied, with injured patients to follow later this year. Trough- out this process, questions have been posed and answered, processes revised and physi- cal changes made before even more testing takes place. Tis is the life cycle of this kind of technology.


But the promise of MTEC extends far beyond just the initial


idea. Overall,


more than 40 percent of MTEC’s roster of successful projects have secured follow- on funding from either the government or the corporate sector that continues to invest in the prototype’s advancement with the ultimate goal being to turn the device into a final, polished product.


“Tere are a lot of parties that are just now becoming familiar with MTEC,” said Palestrini. “It’s got this added benefit where everyone—investors, venture capi- tal groups working through our expanded programs for commercialization, indus- try partners, the foundations we work


with—can come into the mix to get a sense of what the government is funding for the military and then, also, what they can piggyback onto for a civilian use case.”


Allan and Wijesundara are hoping for similar success. For Allan specifically, the ReHeal Glove would be the answer to a problem he’s been trying to tackle for his entire career.


“I used to wish for a device like this,” said Allan, firm in his belief the ReHeal Glove could lead to a dramatic improvement in outcomes across the board—including quicker recovery times. “We expect that it’s going to fill a gap that I’ve observed—and also that my colleagues have observed— over the past 20 years.”


For more information about USAMRDC, go to https://mrdc.amedd.army.mil/. To learn more about MTEC, go to https://www.mtec-sc.org. To see a video about the ReHeal Glove go to ht t p s : //www. y o u t u b e . c om / w a t ch ? v = N 2n a 9d s v N L Y . To learn more about the consortium model, go to https://asc.army.mil/web/news-not- far-at-all/.


RAMIN A. KHALILI is a writer with USAMRDC’s public affairs office. Before assuming his current role, he spent five years as the knowledge manager for USAMRDC’s Combat Casualty Care Research Program. During his previous work as a broadcast journalist, he earned an Associated Press Award for his work in Phoenix, Arizona, before serving as chief NASA correspondent for CBS in Orlando, Florida. He holds a B.A. in communications from Penn State University. He is a frequent contributor to Army AL&T, and his most recent piece for Army AL&T was “Double Time” in the Spring 2022 issue.


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84  |  Page 85  |  Page 86  |  Page 87  |  Page 88  |  Page 89  |  Page 90  |  Page 91  |  Page 92  |  Page 93  |  Page 94  |  Page 95  |  Page 96  |  Page 97  |  Page 98  |  Page 99  |  Page 100  |  Page 101  |  Page 102  |  Page 103  |  Page 104  |  Page 105  |  Page 106  |  Page 107  |  Page 108  |  Page 109  |  Page 110  |  Page 111  |  Page 112  |  Page 113  |  Page 114  |  Page 115  |  Page 116  |  Page 117  |  Page 118  |  Page 119  |  Page 120  |  Page 121  |  Page 122